From: Pathological perspective reveals a novel hemodialyzer reaction: a case report
Variable | Initiation of dialysis (2 weeks before dialysis) | Recurrent yellowish-white deposits formation in the hemodialysis tubing (3 months after deposits formation) | Disappearance of yellowish-white deposits (2 months after the disappearance of deposits) | Reference range |
---|---|---|---|---|
C-reactive protein, mg/L | 13.54 | 1.85 | <0.50 | 0–10 |
White blood cell count, x109/L | 5.96 | 7.71 | 5.65 | 3.5–9.5 |
Hemoglobin, g/L | 90 | 53 | 119 | 130–175 |
Platelets, x109/L | 216 | 411 | 455 | 125–350 |
Neutrophil ratio, % | 74 | 79.6 | 71.3 | 40–75 |
Lymphocyte ratio, % | 13.3 | 8.7 | 13.1 | 20–50 |
Monocyte ratio, % | 5.5 | 5.4 | 5.3 | 3–10 |
Eosinophil ratio, % | 5.90 | 6.00 | 8.4 | 0.4-8 |
Basophil ratio, % | 1.30 | 0.30 | 1.9 | 0–1 |
D-dimer test, mg/L FEU | 0.41 | - | - | 0-0.8 |
International normalized ratio | 1.07 | - | - | 0.82–1.15 |
Activated partial thromboplastin time, s | 27.6 | - | - | 22.3–32.5 |
Fibrin degradation products, mg/L | 2.5 | - | - | 0–5 |
Triglyceride, mmol/L | 1.3 | - | - | 0.45–1.81 |
Total cholesterol, mmol/L | 2.98 | - | - | 2.8–5.9 |
High-density lipoprotein cholesterol, mmol | 0.83 | - | - | >1.03 |
Low-density lipoprotein cholesterol, mmol/L | 1.78 | - | - | <4.10 |
urea, mmol/L | 20.96 | 17.76 | 13.26 | 2.8–7.2 |
Serum creatinine, umol/L | 769 | 799 | 718 | 64–104 |
Uric acid, umol/L | 529 | 558 | 377 | 208.3-428.4 |
Serum phosphorus, mmol/L | 1.68 | 1.88 | 1.55 | 0.81–1.45 |
Parathyroid hormone, ng/L | 261.5 | 271.5 | 276.8 | 15–65 |
Serum potassium, mmol/L | 5.01 | 3.65 | 4.47 | 3.5–5.1 |
Serum sodium, mmol/L | 130.6 | 140 | 140 | 136–146 |
Serum chloride, mmol/L | 101.0 | 103 | 104 | 101–109 |
Serum calcium, mmol/L | 1.90 | 2.11 | 1.98 | 2.2–2.65 |
Carbon dioxide, mol/L | 18.5 | 21.25 | 20.12 | 20–29 |
Serum albumin, g/L | 33.6 | 37.11 | 37.87 | 35–52 |
Alanine transaminase, U/L | 19 | 7 | 13 | 0–50 |
Aspartate transaminase, U/L | 19 | 10 | 15 | 0–50 |